So, based on their earlier statement of:
"We have not yet set a time for the clinical study, but once the formulation and preclinical plan are resolved, we will be providing a more precise timeline for moving ahead to a clinical program."
...and that they're now setting a timeline, can we assume they have resolved the bio-availability issue they were concerned about earlier?
If so, that's awesome.
Any idea what "initiation" of trial means? Is that when they start planning it, or start doing it? Any talk of where it would happen? Their corporate HQ is in CA - is that where this particular project is being worked?
Is Summit out of business now? Were they working on anything else MD related?
Thanks for posting these updates, Ofelia.
Well, the BMN 195 clinical trial has started in healthy volunteers. Let's hope that everything goes as planned and phase 2 will be following up shortly. Has anyone heard anything since it has started?